BIOL

Biolase, Inc.

Delisted

BIOL was delisted on the 18th of June, 2024.

36 hedge funds and large institutions have $30.4M invested in Biolase, Inc. in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

Holders
36
Holders Change
+6
Holders Change %
+20%
% of All Funds
0.96%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.05%
New
7
Increased
1
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
T. Rowe Price Associates
26
T. Rowe Price Associates
Maryland
$23K
Nomura Holdings
27
Nomura Holdings
Japan
$19K +$19K +1 New
GC
28
Guggenheim Capital
Illinois
$17K +$17K +1 New
Commonwealth Equity Services
29
Commonwealth Equity Services
Massachusetts
$16K
BA
30
BlackRock Advisors
Delaware
$15K
LPL Financial
31
LPL Financial
California
$15K +$15K +1 New
TSS
32
Two Sigma Securities
New York
$15K +$15K +1 New
WS
33
Wedbush Securities
California
$14K
UBS Group
34
UBS Group
Switzerland
$12K
BIM
35
BlackRock Investment Management
Delaware
$11K
Bank of America
36
Bank of America
North Carolina
$4K -$2K
TRCT
37
Tower Research Capital (TRC)
New York
$3K -$1K
CG
38
Cutler Group
California
$2K -$1K
Manulife (Manufacturers Life Insurance)
39
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K -$1
JFA
40
JNBA Financial Advisors
Minnesota
$1K -$1K
BC
41
Barnett & Company
Tennessee
$1K
KF
42
Krilogy Financial
Missouri
$1K
Citigroup
43
Citigroup
New York
$1K
LTFS
44
Ladenburg Thalmann Financial Services
Florida
$1K -$1K
Geode Capital Management
45
Geode Capital Management
Massachusetts
$255
IA
46
IFP Advisors
Florida
-$11K -1 Closed
Creative Planning
47
Creative Planning
Kansas
-$1K
AIG
48
American International Group
New York
-$1K